Proceeds from the financing will be used to accelerate the commercialization of the SEM Scanner.

Led by Martin Burns, CEO, Bruin Biometrics provides the SEM Scanner, a hand-held device for detecting early-stage pressure ulcers. It uses non-invasive biosensor technology to measure sub-epidermal moisture (SEM), a biophysical marker associated with localized edema in the initial inflammatory phase of pressure ulcer formation.
Launched in 2014 in the United Kingdom and Ireland after receiving CE Mark approval, the product will be hopefully available in the United States during 2016. To this end, the company is working with the FDA.